InnovAge Holding Corp Outlines Strategic Transition and Fiscal 2027 Outlook
InnovAge Holding Corp concluded fiscal year 2026 by completing its 'InnovAge 2.0' transformation, shifting from regulatory remediation to a disciplined operating model. The company attributed strong performance to improved medical cost management, favorable rate environments, and the successful insourcing of pharmacy services. Looking ahead, InnovAge is launching an 'InnovAge 3.0' strategy focused on scaling its current operations while exploring new markets through M&A and joint ventures. For fiscal year 2027, the company expects a more tempered rate environment with projected net Medicare rate increases between 1.5% to 2.0%. Revenue is forecasted at $1.05B to $1.085B, factoring in assumptions for California and Colorado rates that make up 70% of its census. Strategic initiatives include expanding AI applications for clinical decision support and medication optimization. Management emphasized a preference for M&A over new center development if it offers better returns on invested capital. The company is also engaging with CMS/CMMI to explore regulatory changes, including potential 'pre-PACE' models aimed at delaying Medicaid enrollment among seniors.
Topics: growth_initiatives healthcare operational_strategy senior_care